Status:

RECRUITING

Study on a Prosthetic Foot With Adjustable Heel Height

Lead Sponsor:

Otto Bock France SNC

Conditions:

Lower Limb Amputation Above Knee

Lower Limb Amputation Below Knee

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Most prosthetic feet have a fixed heel height, which requires users to always wear shoes with the same heel height. A fixed heel height is a significant constraint, whereas the ability to choose one's...

Detailed Description

The amputation or absence of a lower limb affects both mobility and appearance, which can lead to restrictions in social, family, and professional participation. The choice of prosthetic components ai...

Eligibility Criteria

Inclusion

  • Inclusion Criteria :
  • Adult patient with a major lower limb amputation whose life project includes:
  • movement in buildings other than the home (ICF d4601),
  • movement outside the home and other buildings (ICF d4602),
  • and other specified activities related to movement in other various places (ICF d4608).
  • Patient who has been using an Enregy storage and Return (ESR) foot for at least 3 months
  • Patient who wishes to walk with shoes with different heel heights, and/or barefoot
  • Exclusion Criteria:
  • Patient with a high impact level (e.g.: sport)
  • Patient with hip disarticulation or equivalent
  • Patient with an unstabilised residual limb and/or an unsuitable socket
  • Patient who cannot be fitted with a Taleo Adjust foot due to the technical characteristics of the product (user weight greater than 115kg; required foot size \<22 or \>28; mounting height less than 118 mm)
  • Patient whose usual foot has a heel height adjustment system
  • Patient unavailable for the duration of the study and/or unable to understand the instructions and/or answer questionnaires in French
  • Patient already participating in another study
  • Patient in an emergency situation or pregnant woman

Exclusion

    Key Trial Info

    Start Date :

    October 8 2025

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    June 6 2026

    Estimated Enrollment :

    30 Patients enrolled

    Trial Details

    Trial ID

    NCT07214493

    Start Date

    October 8 2025

    End Date

    June 6 2026

    Last Update

    November 25 2025

    Active Locations (5)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 2 (5 locations)

    1

    CH Cornouaille

    Concarneau, France

    2

    CHU Grenoble

    Échirolles, France

    3

    IRR Louis Pierquin

    Nancy, France

    4

    CRRF La Tourmaline

    Saint-Herblain, France